Immutep targets $100m for lung cancer drug trial tests
Immutep has launched a capital raise aiming to boost its war chest by $100 million to progress late stage trials for lung cancer sufferers.
Announcements
Filter Results
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
-0.040(3.85%) |
Mkt cap ! $20.39M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | $1.00 | $16.23K | 15.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8053 | 90.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 1458 | 1 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
| LAM (ASX) Chart |
